Advanced search
Start date
Betweenand

Influence of the mTOR, STAT1/3 and iNOS signaling pathways in the activity of tolerogenic dendritic cells

Grant number: 14/19492-3
Support type:Regular Research Grants
Duration: August 01, 2015 - July 31, 2017
Field of knowledge:Biological Sciences - Immunology - Cellular Immunology
Principal researcher:Liana Maria Cardoso Verinaud
Grantee:Liana Maria Cardoso Verinaud
Home Institution: Instituto de Biologia (IB). Universidade Estadual de Campinas (UNICAMP). Campinas , SP, Brazil
Assoc. researchers:Rodolfo Thomé

Abstract

Dendritic cells (DCs) are able to polarize the immune response towards an inflammatory or anti-inflammatory context depending on its maturation/activation status, leading to the generation of regulatory T cells or Th1, Th2, Th9 and Th17 profiles. Immature DCs are also called tolerogenic DCs. An increasing number of studies have demonstrated that DC modulation is an innovative approach to control chronic inflammation observed in most autoimmune diseases, such as Multiple Sclerosis and Rheumatoid Arthritis. In this context, our group demonstrated that chloroquine (CQ), an antimalarial drug, generated tolerogenic dendritic cells (DC-CQ) in vitro. We also demonstrated that DC-CQ induced the differentiation of regulatory T cells while suppressing the activation of effector T cells. Notwithstanding, adoptive transfer of DC-CQ reduced autoimmune neuro-inflammation in a mouse model of Multiple Sclerosis, the Experimental Autoimmune Encephalomyelitis (EAE). These findings foster the possibility of adjunct administration of tolerogenic dendritic cells in the treatment of autoimmune diseases. However, literature data are scarce regarding the signaling pathways involved in the activity of tolerogenic DCs. In this context, this project aim to investigate the influence of the intracellular signaling cascades involved in the metabolic control (mTOR), cytokine signaling (STAT1/3) and effector function (nitric oxide, NO) over the suppressive activity of tolerogenic dendritic cells. We believe that a better understanding of the mechanisms that govern the tolerogenic function of DCs may provide a spectrum of possibilities and discovery of new compounds able to modulate dendritic cells and thus contribute to the development of new approaches in the treatment of autoimmune diseases. (AU)

Articles published in Agência FAPESP Newsletter about the research grant:
Articles published in other media outlets (0 total):
More itemsLess items
VEICULO: TITULO (DATA)
VEICULO: TITULO (DATA)

Scientific publications (4)
(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)
THOMAZ, LIVIA DE LIMA; PERON, GABRIELA; OLIVEIRA, JANINE; DA ROSA, LARISSA CAMARGO; THOME, RODOLFO; VERINAUD, LIANA. The impact of metabolic reprogramming on dendritic cell function. International Immunopharmacology, v. 63, p. 84-93, . (14/19492-3)
THOME, RODOLFO; DE CARVALHO, ANA CAROLINA; DA COSTA, THIAGO ALVES; WATANABE ISHIKAWA, LARISSA LUMI; DE CAMPOS FRAGA-SILVA, THAIS FERNANDA; SARTORI, ALEXANDRINA; RODRIGUES DE OLIVEIRA, ALEXANDRE LEITE; VERINAUD, LIANA. Artesunate Ameliorates Experimental Autoimmune Encephalomyelitis by Inhibiting Leukocyte Migration to the Central Nervous System. CNS Neuroscience & Therapeutics, v. 22, n. 8, p. 707-714, . (14/02631-0, 14/19492-3, 14/11588-1)
DA COSTA, THIAGO ALVES; DI GANGI, ROSARIA; THOME, RODOLFO; FELISBINO, MARINA BARRETO; BONFANTI, AMANDA PIRES; WATANABE ISHIKAWA, LARISSA LUMI; SARTORI, ALEXANDRINA; BURGER, EVA; VERINAUD, LIANA. Severe Changes in Thymic Microenvironment in a Chronic Experimental Model of Paracoccidioidomycosis. PLoS One, v. 11, n. 10, . (14/02631-0, 13/08194-9, 14/19492-3, 12/03238-5, 13/01401-9, 12/22131-7)
THOME, RODOLFO; BONFANTI, AMANDA PIRES; RASOULI, JAVAD; MARI, ELISABETH ROSE; ZHANG, GUANG-XIAN; ROSTAMI, ABDOLMOHAMAD; VERINAUD, LIANA. Chloroquine-treated dendritic cells require STAT1 signaling for their tolerogenic activity. European Journal of Immunology, v. 48, n. 7, p. 1228-1234, . (14/02631-0, 14/19492-3)

Please report errors in scientific publications list by writing to: cdi@fapesp.br.